{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:46:48Z","timestamp":1767984408941,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T00:00:00Z","timestamp":1529712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760115"],"award-info":[{"award-number":["81760115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460118"],"award-info":[{"award-number":["81460118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Education Department Scientific Research Foundation of Jiangxi Province","award":["GJJ160039"],"award-info":[{"award-number":["GJJ160039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10620-018-5168-3","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T01:24:16Z","timestamp":1529717056000},"page":"2662-2672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A COL1A1 Promoter-Controlled Expression of TGF-\u03b2 Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses"],"prefix":"10.1007","volume":"63","author":[{"given":"Shouhua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianxin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"key":"5168_CR1","doi-asserted-by":"publisher","first-page":"d793","DOI":"10.2741\/A812","volume":"7","author":"AM Gressner","year":"2002","unstructured":"Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002;7:d793\u2013d807.","journal-title":"Front Biosci"},{"key":"5168_CR2","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","volume":"275","author":"SL Friedman","year":"2000","unstructured":"Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247\u20132250.","journal-title":"J Biol Chem"},{"key":"5168_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJM199104043241401","volume":"324","author":"A Castilla","year":"1991","unstructured":"Castilla A, Prieto J, Fausto N. Transforming growth factors \u03b21 and \u03b1 in chronic liver disease Effects of interferon alfa therapy. N Eng J Med. 1991;324:933\u2013940.","journal-title":"N Eng J Med"},{"key":"5168_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","volume":"30","author":"C Hellerbrand","year":"1999","unstructured":"Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGF\u03b21 in initiating hepatic stellate cell activation in vivo. J Hepatol. 1999;30:77\u201387.","journal-title":"J Hepatol"},{"key":"5168_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7:425\u2013436.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5168_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00005-015-0333-2","volume":"63","author":"Y Li","year":"2015","unstructured":"Li Y, Wang W, Jia X, et al. A targeted multiple antigenic peptide vaccine augments the immune response to self TGF-\u03b21 and suppresses ongoing hepatic fibrosis. Arch Immunol Ther Exp. 2015;63:305\u2013315.","journal-title":"Arch Immunol Ther Exp"},{"key":"5168_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1053\/jhep.2002.32673","volume":"35","author":"Y Yata","year":"2002","unstructured":"Yata Y, Gotwals P, Koteliansky V, Rockey DC. Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-\u03b2 soluble receptor: implications for antifibrotic therapy. Hepatology. 2002;35:1022\u20131030.","journal-title":"Hepatology"},{"key":"5168_CR8","doi-asserted-by":"publisher","first-page":"9289","DOI":"10.1038\/s41598-017-09673-5","volume":"7","author":"L Wu","year":"2017","unstructured":"Wu L, Zhang Q, Mo W, et al. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-\u03b21\/Smads and PI3K\/Akt pathways. Sci Rep. 2017;7:9289.","journal-title":"Sci Rep"},{"key":"5168_CR9","doi-asserted-by":"publisher","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","volume":"96","author":"J George","year":"1999","unstructured":"George J, Roulot D, Koteliansky VE, Bissell DM. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor \u03b2 type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA. 1999;96:12719\u201312724.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5168_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X-m Meng","year":"2016","unstructured":"Meng X-m, Nikolic-Paterson DJ, Lan HY. TGF-[beta]: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u2013338.","journal-title":"Nat Rev Nephrol"},{"key":"5168_CR11","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","volume":"13","author":"EP B\u00f6ttinger","year":"2002","unstructured":"B\u00f6ttinger EP, Bitzer M. TGF-\u03b2 signaling in renal disease. J Am Soc Nephrol. 2002;13:2600\u20132610.","journal-title":"J Am Soc Nephrol"},{"key":"5168_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/CS20120252","volume":"124","author":"X-M Meng","year":"2013","unstructured":"Meng X-M, Chung AC, Lan HY. Role of the TGF-\u03b2\/BMP-7\/Smad pathways in renal diseases. Clin Sci. 2013;124:243\u2013254.","journal-title":"Clin Sci"},{"key":"5168_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/gut.46.4.443","volume":"46","author":"R Benyon","year":"2000","unstructured":"Benyon R, Iredale J. Is liver fibrosis reversible? Gut. 2000;46:443\u2013446.","journal-title":"Gut"},{"key":"5168_CR14","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0168-8278(17)30271-4","volume":"66","author":"P Shea","year":"2017","unstructured":"Shea P, Hirschfield G, Shiffman M, et al. PS-002-Common variation near glial-derived neurotrophic factor is associated with progression of hepatic collagen content in a genome-wide association study of liver fibrosis phenotypes in patients with primary sclerosing cholangitis. J Hepatol. 2017;66:S4\u2013S5.","journal-title":"J Hepatol"},{"key":"5168_CR15","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1128\/MCB.19.6.4334","volume":"19","author":"B Stefanovic","year":"1999","unstructured":"Stefanovic B, Hellerbrand C, Brenner D. Regulatory role of the conserved stem-loop structure at the 5\u2032 end of collagen \u03b11 (I) mRNA. Mol Cell Biol. 1999;19:4334\u20134342.","journal-title":"Mol Cell Biol"},{"key":"5168_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1359\/jbmr.2002.17.1.15","volume":"17","author":"I Kalajzic","year":"2002","unstructured":"Kalajzic I, Kalajzic Z, Kaliterna M, et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res. 2002;17:15\u201325.","journal-title":"J Bone Miner Res"},{"key":"5168_CR17","doi-asserted-by":"publisher","first-page":"33593","DOI":"10.1038\/srep33593","volume":"6","author":"P Chen","year":"2016","unstructured":"Chen P, Li J, Huo Y, et al. Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Sci Rep. 2016;6:33593.","journal-title":"Sci Rep"},{"key":"5168_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/1756-0500-5-636","volume":"5","author":"SA Khan","year":"2012","unstructured":"Khan SA, Joyce J, Tsuda T. Quantification of active and total transforming growth factor-\u03b2 levels in serum and solid organ tissues by bioassay. BMC Res Notes. 2012;5:636.","journal-title":"BMC Res Notes"},{"key":"5168_CR19","doi-asserted-by":"publisher","first-page":"e82190","DOI":"10.1371\/journal.pone.0082190","volume":"8","author":"X Fan","year":"2013","unstructured":"Fan X, Zhang Q, Li S, et al. Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-\u03b21. PLoS ONE. 2013;8:e82190.","journal-title":"PLoS ONE"},{"key":"5168_CR20","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.4049\/jimmunol.1300120","volume":"191","author":"K Hu","year":"2013","unstructured":"Hu K, Luo S, Tong L, et al. CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue. J Immunol. 2013;191:1935\u20131947.","journal-title":"J Immunol"},{"key":"5168_CR21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1164\/ajrccm.163.3.2006084","volume":"163","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Galt T, et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med. 2001;163:770\u2013777.","journal-title":"Am J Respir Crit Care Med"},{"key":"5168_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","volume":"49","author":"K Kaji","year":"2014","unstructured":"Kaji K, Yoshiji H, Ikenaka Y, et al. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol. 2014;49:481\u2013491.","journal-title":"J Gastroenterol"},{"key":"5168_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jgm.1303","volume":"11","author":"A Marquez-Aguirre","year":"2009","unstructured":"Marquez-Aguirre A, Sandoval-Rodriguez A, Gonzalez-Cuevas J, et al. Adenoviral delivery of dominant-negative transforming growth factor \u03b2 type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats. J Gene Med. 2009;11:207\u2013219.","journal-title":"J Gene Med"},{"key":"5168_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0168-8278(01)00260-4","volume":"36","author":"D Cassiman","year":"2002","unstructured":"Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell\/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol. 2002;36:200\u2013209.","journal-title":"J Hepatol"},{"key":"5168_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.autrev.2005.03.006","volume":"4","author":"CA Aoki","year":"2005","unstructured":"Aoki CA, Borchers AT, Li M, et al. Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun Rev. 2005;4:450\u2013459.","journal-title":"Autoimmun Rev"},{"key":"5168_CR26","doi-asserted-by":"crossref","first-page":"36984","DOI":"10.18632\/oncotarget.6100","volume":"6","author":"XM Meng","year":"2015","unstructured":"Meng XM, Zhang Y, Huang XR, Ren GL, Li J, Lan HY. Treatment of renal fibrosis by rebalancing TGF-beta\/Smad signaling with the combination of asiatic acid and naringenin. Oncotarget. 2015;6:36984\u201336997.","journal-title":"Oncotarget"},{"key":"5168_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.10.047","volume":"76","author":"V Kumar","year":"2016","unstructured":"Kumar V, Mondal G, Dutta R, Mahato RI. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis. Biomaterials. 2016;76:144\u2013156.","journal-title":"Biomaterials"},{"key":"5168_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.biochi.2016.06.007","volume":"131","author":"EM Smekalova","year":"2016","unstructured":"Smekalova EM, Kotelevtsev YV, Leboeuf D, et al. lncRNA in the liver: prospects for fundamental research and therapy by RNA interference. Biochimie. 2016;131:159\u2013172.","journal-title":"Biochimie"},{"key":"5168_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-6-1","volume":"6","author":"K Beneden Van","year":"2013","unstructured":"Van Beneden K, Mannaerts I, Pauwels M, Van den Branden C, Van Grunsven LA. HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair. 2013;6:1.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"5168_CR30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1164\/ajrccm.163.3.2006084","volume":"163","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Galt T, et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med. 2001;163:770\u2013777.","journal-title":"Am J Respir Crit Care Med"},{"key":"5168_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.autrev.2005.03.006","volume":"4","author":"CA Aoki","year":"2005","unstructured":"Aoki CA, Borchers AT, Li M, et al. Transforming growth factor \u03b2 (TGF-\u03b2) and autoimmunity. Autoimmun Rev. 2005;4:450\u2013459.","journal-title":"Autoimmun Rev"},{"key":"5168_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0092-8674(88)80033-3","volume":"52","author":"P Rossi","year":"1988","unstructured":"Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-\u03b2. Cell. 1988;52:405\u2013414.","journal-title":"Cell"},{"key":"5168_CR33","doi-asserted-by":"crossref","first-page":"13625","DOI":"10.1016\/S0021-9258(19)38694-6","volume":"268","author":"JD Ritzenthaler","year":"1993","unstructured":"Ritzenthaler JD, Goldstein RH, Fine A, Smith BD. Regulation of the alpha 1 (I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem. 1993;268:13625\u201313631.","journal-title":"J Biol Chem"},{"key":"5168_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","volume":"47","author":"B Hinz","year":"2015","unstructured":"Hinz B. The extracellular matrix and transforming growth factor-\u03b21: tale of a strained relationship. Matrix Biol. 2015;47:54\u201365.","journal-title":"Matrix Biol"},{"key":"5168_CR35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/gut.2006.092460","volume":"56","author":"K Kinoshita","year":"2007","unstructured":"Kinoshita K, Iimuro Y, Otogawa K, et al. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut. 2007;56:706\u2013714.","journal-title":"Gut"},{"key":"5168_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijpharm.2013.11.041","volume":"459","author":"D Ibraheem","year":"2014","unstructured":"Ibraheem D, Elaissari A, Fessi H. Gene therapy and DNA delivery systems. Int J Pharm. 2014;459:70\u201383.","journal-title":"Int J Pharm"},{"key":"5168_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/vaccines4040039","volume":"4","author":"K Lundstrom","year":"2016","unstructured":"Lundstrom K, Replicon RNA. Viral vectors as vaccines. Vaccines. 2016;4:39.","journal-title":"Vaccines"},{"key":"5168_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/v2020413","volume":"2","author":"G Zimmer","year":"2010","unstructured":"Zimmer G. RNA replicons\u2014a new approach for influenza virus immunoprophylaxis. Viruses. 2010;2:413\u2013434.","journal-title":"Viruses"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T05:58:13Z","timestamp":1661493493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,23]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["5168"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5168-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,23]]},"assertion":[{"value":"4 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}